Ritlecitinib is a pyrrolopyrimidine compound that functions as a dual inhibitor of Janus kinase 3 and the TEC family of tyrosine kinases. It is an anti-inflammatory and immunosuppressive agent, used primarily for research and pharmaceutical manufacturing as an active pharmaceutical ingredient.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1792180-81-4
Ritlecitinib tosylate
active pharmaceutical ingredient
Daridorexant hydrochloride
active pharmaceutical ingredient
Magnesium lactate dihydrate
magnesium supplement active ingredient
보르테조밉
active pharmaceutical ingredient
Caspofungin acetate
active pharmaceutical ingredient
N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
n.a
Tofacitinib
active pharmaceutical ingredient
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
active pharmaceutical ingredient
1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
CBRJPFGIXUFMTM-WDEREUQCSA-N
C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3